SCHEMBL5775498

SCHEMBL5775498

CCCC1=NCCc2ccc(Br)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
RCE1 Q9Y256 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP1 P09874 1/20 0.37
PARP10 Q53GL7 1/20 0.37
TYMS P04818 2/20 0.35
ALDH1A1 P00352 1/20 0.34
ADRA2A P08913 1/20 0.33
PNMT P11086 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
CHEK2 O96017 1/20 0.33
ROS1 P08922 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8484264 0.91 CYP1A2 (0.40) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL2967279 0.84 ADRA2A (0.34) TDP1L3MBTL1PARP1PARP10TYMS
SCHEMBL30345337 0.79 NPC1 (0.40) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL5778347 0.78 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL4778415 0.77 KDM4E (0.55) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL7513554 0.76 KDM4E (0.41) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL31173460 0.76 KDM4E (0.41) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL29405492 0.75 MAOA (0.50) KDM4ETDP1L3MBTL1PARP1PARP10
SCHEMBL1009165 0.75 MAOA (0.50) KDM4ETDP1L3MBTL1PARP1PARP10
SCHEMBL4103388 0.72 CYP1A2 (0.76) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276722-B1 NAPHTHAMIDINE UROKINASE INHIBITORS ABBOTT LAB (US) 2006-03-08 EP disclosed
US-6504031-B1 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents ABBOTT LABORATORIES 2003-01-07 US disclosed
US-6495562-B1 SUCH AS 6-(2-(4,4-DIETHYL-1-ISOPROPYL-3,4-DIHYDRO-6-ISOQUINOLINYL)CYCLOPROPYL)-2 -NAPHTHALENECARBOXIMIDAMIDE ABBOTT LABORATORIES 2002-12-17 US disclosed